TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. Ca A Cancer J Clin. 2014;67:7. doi:10.3322/caac.21387.
   Google Scholar
• Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002;5:5–11.
   PubMedGoogle Scholar
• Herszényi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci. 2010;14:249–258.
   PubMed Web of Science ®Google Scholar
• Tominaga S. Epidemiologic trends of stomach cancer in Japan and world. Nihon Rinsho. 2001;59(Suppl 4):5.
   PubMedGoogle Scholar
• Kagawa S, Shigeyasu K, Ishida M, Watanabe M, Tazawa H, Nagasaka T, Shirakawa Y, Fujiwara T. Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients. World J Gastroenterol. 2014;20:17796. doi:10.3748/wjg.v20.i47.17796.
   PubMed Web of Science ®Google Scholar
• Zong L, Abe M, Seto Y, Ji J. The challenge of screening for early gastric cancer in China. Lancet. 2016;388:2606. doi:10.1016/S0140-6736(16)32226-7.
   PubMed Web of Science ®Google Scholar
• Jamal A, Swarnalatha M, Sultana S, Joshi P, Panda SK, Kumar V. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2. Cell Cycle. 2015;14:2688–2700. doi:10.1080/15384101.2015.1056946.
   PubMed Web of Science ®Google Scholar
• Hyungsoo K, Frederick DT, Levesque MP, Cooper ZA, Feng Y, Clemens K, Brill L, Samuels Y, Hayward NK, Perlina A, et al. Downregulation of the ubiquitin ligase RNF125 underlies resistance of melanoma cells to BRAF inhibitors via JAK1 deregulation. Cell Rep. 2015;11:1458–1473. doi:10.1016/j.celrep.2015.04.049.
   PubMed Web of Science ®Google Scholar
• Snoek BC, De Wilt LH, Jansen G, Peters GJ. Role of E3 ubiquitin ligases in lung cancer. World J Clin Oncol. 2013;4:58–69. doi:10.5306/wjco.v4.i3.58.
   PubMedGoogle Scholar
• Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, et al. The tripartite motif family identifies cell compartments. Embo J. 2014;20:2140–2151. doi:10.1093/emboj/20.9.2140.
   Google Scholar
• Ozato K, Shin DM, Chang TH, Iii HCM. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol. 2008;8:849. doi:10.1038/nri2413.
   PubMed Web of Science ®Google Scholar
• Napolitano LM, Meroni G. TRIM family: pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life. 2012;64:64–71. doi:10.1002/iub.580.
   PubMed Web of Science ®Google Scholar
• Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer. 2011;770:792–804. doi:10.1038/nrc3139.
   Google Scholar
• Qiu X, Huang Y, Zhou Y, Zheng F. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication. Oncol Rep. 2016;36:811–818.
   Web of Science ®Google Scholar
• Kajiura K, Masuda K, Naruto T, Kohmoto T, Watabnabe M, Tsuboi M, Takizawa H, Kondo K, Tangoku A, Imoto I. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma. Oncotarget. 2016;8:2890.
   Google Scholar
• Liu M, Zhang X, Cai J, Li Y, Luo Q, Wu H, Yang Z, Wang L, Chen D. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion. Oncol Rep. 2018;40:1251–1260.
   Google Scholar
• He T, Sparks AB, Rago C, Hermeking H, Zawel L, Costa L, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a Target of the APC Pathway. Science. 1998;281:1509. doi:10.1126/science.281.5382.1509.
   PubMed Web of Science ®Google Scholar
• Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426. doi:10.1038/18884.
   PubMed Web of Science ®Google Scholar
• Nguyen DX, Chiang AC, Zhang XHF, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massagué J. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell. 2009;138:51–62. doi:10.1016/j.cell.2009.04.030.
   PubMed Web of Science ®Google Scholar
• Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Mimori K, Tanaka F, Watanabe M, Mori M. Tripartite motif-containing 29 (TRIM29) is a novel marker for Lymph node metastasis in gastric cancer. Ann Surg Oncol. 2007;14:2543–2549. doi:10.1245/s10434-007-9461-1.
   PubMed Web of Science ®Google Scholar
• Feng Q, Jian-Ping X, Jun D, Xiao-Jun X. TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185. Int J Clin Exp Pathol. 2015;8:5053–5061.
   PubMed Web of Science ®Google Scholar
• Lee JH, Park CH, Jung KC, Rhee HS, Yang CH. Negative regulation of β-catenin/Tcf signaling by naringenin in AGS gastric cancer cell. Biochem Biophys Res Commun. 2005;335:771–776. doi:10.1016/j.bbrc.2005.07.146.
   PubMed Web of Science ®Google Scholar
• Ikenoue T, Ijichi H, Kato N, Kanai F, Masaki T, Rengifo W, Okamoto M, Matsumura M, Kawabe T, Shiratori Y, et al. Analysis of the β‐catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res. 2002;93:1213–1220. doi:10.1111/j.1349-7006.2002.tb01226.x.
   PubMedGoogle Scholar
• Yang X-Z, Cheng -T-T, He Q-J, Lei Z-Y, Chi J, Tang Z, Liao Q-X, Zhang H, Zeng L-S, Cui S-Z. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Mol Cancer. 2018;17:126. doi:10.1186/s12943-018-0874-1.
   PubMed Web of Science ®Google Scholar
• Wang L, Guo J, Wang Q, Zhou J, Xu C, Teng R, Chen Y, Wei Q, Liu Z-P. LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of β-catenin. J Cancer Res Clin Oncol. 2014;140:1997–2008. doi:10.1007/s00432-014-1753-9.
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Fu H, Zhang Y, Zhang X, Yang D, Zhu Z, Wei Z, Hu Z, Yan R, et al. TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer. J Cell Mol Med. 2018;22:5020–5028. doi:10.1111/jcmm.13784.
   PubMed Web of Science ®Google Scholar
• Hong JY, Kang B, Kim A, Hwang S, Ahn J, Lee S, Kim J, Park J-H, Cheon D-S. Development of a highly sensitive real-time one step RT-PCR combined complementary locked primer technology and conjugated minor groove binder probe. Virol J. 2011;8:330. doi:10.1186/1743-422X-8-330.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789–799. doi:10.1038/nm1087.
   PubMed Web of Science ®Google Scholar
• Klopfleisch R, Gruber AD. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands. Res Vet Sci. 2009;87:91–96. doi:10.1016/j.rvsc.2008.12.010.
   PubMed Web of Science ®Google Scholar
• Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 1991;6:1915–1922.
   PubMed Web of Science ®Google Scholar
• Shin S, Sung B-J, Cho Y-S, Kim H-J, Ha N-C, Hwang J-I, Chung CW, Jung YK, Oh BH. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and −7. Biochemistry. 2001;40:1117–1123. doi:10.1021/bi001603q.
   PubMed Web of Science ®Google Scholar
• Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M, Montagna L, Piccoli P, Chilosi M, Caligaris-Cappio F. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood. 2001;97:2777–2783. doi:10.1182/blood.v97.9.2777.
   PubMed Web of Science ®Google Scholar
• Lim JH, Park JW, Chun YS. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res. 2006;66:10677. doi:10.1158/0008-5472.CAN-06-3171.
   PubMed Web of Science ®Google Scholar
• Wang Y, He D, Yang L, Wen B, Dai J, Zhang Q, Kang J, He W, Ding Q, He D. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis. Biochem Biophys Res Commun. 2015;463:458–465. doi:10.1016/j.bbrc.2015.05.117.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S, Lu X, Liu Y, Chen Y, Shen R, et al. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Tumor Biol. 2016;37:1–14. doi:10.1007/s13277-016-5316-3.
   Google Scholar
• Palmbos PL, Lidong W, Huibin Y, Yin W, Jacob L, Ahmet MKL, Wilkinson JE, Kumar-Sinha C, Ney GM, Tomlins SA, et al. ATDC/TRIM29 drives invasive bladder cancer formation through miRNA-mediated and epigenetic mechanisms. Cancer Res. 2015;75:5155–5166. doi:10.1158/0008-5472.CAN-15-0603.
   PubMed Web of Science ®Google Scholar
• Sanchita B, Claude G, Lynn C, Jianhong O, Xiaochun Z, Tushir JS, Virbasius C-M, Lin L, Zhu LJ, Wajapeyee N, et al. TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein. Nature. 2014;516:116–120. doi:10.1038/nature13955.
   PubMed Web of Science ®Google Scholar
• Li Z, Li X, Wei D, Sun C, Guo D, Zhang L. Mmu-miR-1894-3p inhibits cell proliferation and migration of breast cancer cells by targeting Trim46. Int J Mol Sci. 2016;17:609. doi:10.3390/ijms17040609.
   Web of Science ®Google Scholar
• Shi L, Wu YX, Yu JH, Chen X, Luo XJ, Yin YR. Research of the relationship between β-catenin and c-myc-mediated Wnt pathway and laterally spreading tumors occurrence. Eur Rev Med Pharmacol Sci. 2017;21:252.
   PubMed Web of Science ®Google Scholar
• Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A. 2000;97:4262–4266. doi:10.1073/pnas.060025397.
   PubMed Web of Science ®Google Scholar
• Wen ZH, Zhou XJ, Pathology DO. The expression and correlation of β-catenin and survivin in nasopharyngeal carcinoma. Jilin Med J. 2018; 39:608-609.
   Google Scholar
• Hai W, Haiyan W, Mohammad Shahidul M, Juanjuan W, Yingqing D, Qunli S, Liu Q, Zhou X, Wang J. Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas. Int J Clin Exp Pathol. 2013;7:264–271.
   PubMed Web of Science ®Google Scholar
• Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res. 1996;68:67–108.
   PubMed Web of Science ®Google Scholar
• Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol. 1995;15:2600–2611. doi:10.1128/mcb.15.5.2600.
   PubMed Web of Science ®Google Scholar
• Clements WM, Wang J, Sarnaik A, Kim OJ, Macdonald J, Fenogliopreiser C, Groden J, Lowy AM. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 2002;62:3503–3506.
   PubMed Web of Science ®Google Scholar
• Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang J-M. Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol. 2002;8:987–993. doi:10.3748/wjg.v8.i6.987.
   PubMed Web of Science ®Google Scholar
• Miao ZF, Wang ZN, Zhao TT, Xu YY, Wu JH, Liu XY, Xu H, You Y, Xu H-M. TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance. Virchows Archiv. 2015;466:525–532. doi:10.1007/s00428-015-1737-4.
   PubMed Web of Science ®Google Scholar
• Takeyuki S. The cellular level of TRIM31, an RBCC protein overexpressed in gastric cancer, is regulated by multiple mechanisms including the ubiquitin-proteasome system. Cell Biol Int. 2013;35:657–661.
   Web of Science ®Google Scholar